Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Strid, H.
Right arrow Articles by Björnsson, E. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strid, H.
Right arrow Articles by Björnsson, E. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2003) 18: 570-575
© 2003 European Renal Association-European Dialysis and Transplant Association

Overuse of acid suppressant drugs in patients with chronic renal failure

Hans Strid, Magnus Simrén and Einar S. Björnsson

Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Göteborg, Sweden

Background. Patients with chronic renal failure (CRF) have a high prevalence of gastrointestinal symptoms. The use of acid suppressive therapy (AST) in these patients is unexplored. We assessed the use of and indication for AST in CRF patients and compared them with hospitalized patients and patients with another chronic disease.

Methods. A total of 293 patients with CRF were compared with 261 hospitalized patients and 181 patients with another chronic disease. Information about AST, endoscopic investigations and indication for therapy were obtained by medical records and patient interviews.

Results. The use of AST was higher in CRF patients (41%, P<0.001) compared with hospitalized patients (13%) and patients with a chronic lung disease (18%), but similar in patients with a rheumatic disease (34%). Inadequate use of AST was high in CRF patients (63%) and hospitalized patients (81%), but lower in patients with another chronic disease (32%, P<0.01). Endoscopic investigations were performed in 41–46% of the patients. More than 90% of AST consisted of proton pump inhibitors (PPIs).

Conclusion. The majority of CRF patients had an inadequate indication for AST. Endoscopy seemed to be underused in these patients. PPIs were the dominating acid suppressive drug.

Keywords: acid suppressive therapy; chronic renal failure; oesophagogastroduodenoscopy; H2-receptor antagonists; proton pump inhibitors

Correspondence and offprint requests to: Hans Strid, Department of Internal Medicine, Sahlgrenska University Hospital, SE-41345 Göteborg, Sweden. Email: hans{at}mbox342.swipnet.se


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am J Health Syst PharmHome page
R. R. A. Grube and D. B. May
Stress ulcer prophylaxis in hospitalized patients not in intensive care units
Am. J. Health Syst. Pharm., July 1, 2007; 64(13): 1396 - 1400.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.